Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons
- PMID: 17440148
- DOI: 10.1001/jama.297.15.1711
Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons
Comment on
-
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.JAMA. 2007 Apr 18;297(15):1657-66. doi: 10.1001/jama.297.15.joc70035. Epub 2007 Mar 26. JAMA. 2007. PMID: 17387132 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
